vegf-a165/bfgf
Gene therapyexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2004 (NCT00620217)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Basic fibroblast growth factorSupplementation
FGF2 supplementation
- Vascular endothelial growth factor ASupplementation
VEGFA supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vegf-a165/bfgf
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00620217 | Phase 2 | Dec 1, 2004 | Government of Poland, Institute of Cardiology, Warsaw, Poland, Medical University of Warsaw, Polpharma Foundation for Development of Polish Pharmacy and Medicine |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Poland | Government | 1 | 0 | 1 | 2004 |
| Institute of Cardiology, Warsaw, Poland | Academic/Hospital | 1 | 1 | 1 | 2004 |
| Medical University of Warsaw | Academic/Hospital | 1 | 0 | 1 | 2004 |
| Polpharma Foundation for Development of Polish Pharmacy and Medicine | Academic/Hospital | 1 | 0 | 1 | 2004 |
4 organizations
Page 1 / 1